Another company recalls fentaynl patch

Different manufacturer, same problem. Another company is recalling painkiller patches because of a flaw that could cause patients or caregivers to overdose on the fentanyl drug inside.

The new recall covers 14 lots of patches sold by Actavis; they have that company's name and its former name, Abrika Pharmaceuticals, on their packaging. Actavis said its patches have a "foldover defect" that might cause leaks. Last week, PriCara, a division of Johnson & Johnson withdrew batches of its Duragesic fentanyl patches. In the latter case, some of the patches had slits in the drug reservoir, leaking fentanyl into the packaging.

Quite a coincidence. Or did the news of J&J's recall alert Actavis to the possibility of a design flaw in its own product?

- see Actavis' release
- see the news in the Washington Post

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.